BioXcel Therapeutics, Inc. (BTAI) CEO Vimal Mehta on Q1 2019 Results - Earnings Call Transcript [Seeking Alpha]
BioXcel Therapeutics, Inc. (BTAI)
Last bioxcel therapeutics, inc. earnings: 11/14 07:00 am
Check Earnings Report
Company Research
Source: Seeking Alpha
BioXcel Therapeutics, Inc. (BTAI) CEO Vimal Mehta on Q1 2019 Results - Earnings Call Transcript BioXcel Therapeutics, Inc. (NASDAQ: BTAI Company Participants Brian Johnston - AVP-IR, The Ruth Group Vimal Mehta - Founder, CEO, President, Secretary & Director Richard Steinhart - CFO Vincent O'Neill - SVP & Chief Medical Officer Frank Yocca - Chief Scientific Officer Conference Call Participants Raghuram Selvaraju - H.C. Wainwright & Company Sumant Kulkarni - Canaccord Genuity Operator Good day, everyone, and welcome to the BioXcel Therapeutics' First Quarter 2019 Earnings Call. Today's conference is being recorded. At this time, I would like to turn the conference over to Mr. Brian Johnston at The Ruth Group. Please go ahead, sir. Thank you, operator. Just to remind everyone, certain matters discussed in today's conference call or answers that may be given to questions asked are forward-looking statements that are subject to risks and uncertainties relating to future events and/or the f
Show less
Read more
Impact Snapshot
Event Time:
BTAI
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BTAI alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BTAI alerts
High impacting BioXcel Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
BTAI
News
- What To Expect From BioXcel Therapeutics Inc (BTAI) Q3 2024 Earnings [Yahoo! Finance]Yahoo! Finance
- BioXcel Therapeutics Advances Pivotal Phase 3 Trials of BXCL501 for Acute Treatment of Agitation Associated with Bipolar Disorders, Schizophrenia, and Alzheimer’s DementiaGlobeNewswire
- BioXcel Therapeutics to Report Third Quarter 2024 Financial Results on November 14, 2024GlobeNewswire
- Will BioXcel Therapeutics, Inc. (BTAI) Report Negative Q3 Earnings? What You Should Know [Yahoo! Finance]Yahoo! Finance
- BioXcel Therapeutics to Present at ThinkEquity ConferenceGlobeNewswire
BTAI
Earnings
- 8/6/24 - Beat
BTAI
Sec Filings
- 10/9/24 - Form 8-K
- 10/3/24 - Form 4
- 10/3/24 - Form 4
- BTAI's page on the SEC website